Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
all 179546 studies found for:    ALL
Show Display Options
Rank Status Study
1 Completed PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Procedure: computed tomography;   Procedure: positron emission tomography;   Procedure: radionuclide imaging;   Radiation: fludeoxyglucose F 18
2 Terminated Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors
Condition: Primary Central Nervous System Lymphoma (PCNSL)
Intervention:
3 Terminated Tenecteplase Pulmonary Embolism Italian Study
Condition: Pulmonary Embolism
Intervention: Drug: tenecteplase
4 Completed Study of Treatment for Adolescents With Bulimia Nervosa
Condition: Bulimia
Interventions: Behavioral: Cognitive Behavioral Therapy for Adolescents;   Behavioral: Supportive Psychotherapy;   Behavioral: Family Based Therapy for Bulimia Nervosa
5 Terminated A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)(TERMINATED)
Condition: Cancer
Intervention: Drug: VX-680 (an Aurora Kinase Inhibitor)
6 Completed 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Condition: Leukemia
Interventions: Drug: 3 Day Thiarabine;   Drug: 5 Day Thiarabine
7 Completed Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: Topotecan
8 Withdrawn Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Duodenal Neoplasms
Interventions: Procedure: surgery;   Procedure: endoscopic strategy
9 Unknown  Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Condition: Impaired Glucose Tolerance
Interventions: Drug: Saxagliptin;   Drug: Placebo
10 Completed
Has Results
A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Herceptin
11 Completed Raltegravir and Ezetimibe PK Study
Condition: HIV
Interventions: Drug: Raltegravir and ezetimibe;   Drug: Ezetimibe and raltegravir
12 Terminated Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Condition: Sickle Cell Disease
Interventions: Drug: nitric oxide;   Drug: oxygen
13 Completed Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse
Condition: Child Abuse
Intervention: Behavioral: Home Visiting
14 Completed A Study of Family-based Cognitive-behavioral Therapy for Chronic Pediatric Headache and Anxiety
Conditions: Pediatric;   Headache;   Anxiety
Intervention: Behavioral: CBT or relaxation training
15 Recruiting Recovery After Sugammadex(Propofol vs Sevoflurane)
Condition: Anesthesia
Intervention: Drug: Sugammadex
16 Recruiting Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies
Condition: NAS
Intervention: Other: Acupuncture
17 Completed Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Biological: sargramostim;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: umbilical cord blood transplantation
18 Recruiting Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas
Conditions: Advanced Solid Tumor;   Lymphoma
Intervention: Drug: DS-8273a
19 Completed Structured Treatment Interruption for HIV Patients With Virologic Failure
Condition: HIV
Intervention: Drug: therapeutic management strategy
20 Active, not recruiting Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
Condition: Coronary Artery Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years